Deals this week: eFFECTOR Therapeutics, VenatoRx Pharmaceuticals, Kezar Life Sciences

US-based biotech company eFFECTOR Therapeutics has secured $38.6m in a series C venture financing round led by Pfizer Venture Investments (PVI).
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news